Inside the Development of Cell and Gene Therapies

More than 25 cell and gene therapy products have been approved by the FDA, and this burgeoning class of treatments is experiencing its own explosive growth. As more of these potentially curative therapies reach patients, the industry continues to experiment with solutions to grapple with growing pains.

Included in this Trendline:

  • The M&A hunt is on — here are the prime targets
  • Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck
  • Multimillion-dollar therapies are changing how payers foot the bill

Request Free!